Alyssa N. Nylander

Neurology

1651 4th St Ste 252
San Francisco, CA 94158

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Facial Expression Metrics as Digital Biomarkers of Neurologic Disease.

Facial Expression Metrics as Digital Biomarkers of Neurologic Disease.

Journal: Neurology open access

Published: July 15, 2026

Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple Sclerosis.

Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple Sclerosis.

Journal: Neurology

Published: December 23, 2024

From "invisible" to "audible": Features extracted during simple speech tasks classify patient-reported fatigue in multiple sclerosis.

From "invisible" to "audible": Features extracted during simple speech tasks classify patient-reported fatigue in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 18, 2024

Well-being at midlife: Correlates of mental health in ambulatory menopausal women with multiple sclerosis.

Well-being at midlife: Correlates of mental health in ambulatory menopausal women with multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 16, 2023

Cognitive function influences cognitive-motor interference during dual task walking in multiple sclerosis.

Cognitive function influences cognitive-motor interference during dual task walking in multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: August 12, 2023

Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis.

Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: July 07, 2023

Clinical course of multiple sclerosis and patient experiences during breast cancer treatment.

Clinical course of multiple sclerosis and patient experiences during breast cancer treatment.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 09, 2023

A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrack.

A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrack.

Journal: JMIR human factors

Published: May 26, 2023

Re-WRAP (Remyelination for women at risk of axonal loss and progression): A phase II randomized placebo-controlled delayed-start trial of bazedoxifene for myelin repair in multiple sclerosis.

Re-WRAP (Remyelination for women at risk of axonal loss and progression): A phase II randomized placebo-controlled delayed-start trial of bazedoxifene for myelin repair in multiple sclerosis.

Journal: Contemporary clinical trials

Published: May 26, 2023

Podoplanin is a negative regulator of Th17 inflammation.

Podoplanin is a negative regulator of Th17 inflammation.

Journal: JCI insight

Published: December 15, 2016

CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment.

CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment.

Journal: Neurology

Published: October 23, 2015

B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.

B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.

Journal: Science translational medicine

Published: August 08, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026